Effects of Combination of Estradiol with Selective Progesterone Receptor Modulators (SPRMs) on Human Breast Cancer Cells In Vitro and In Vivo

Use of estrogen or estrogen / progestin combination was an approved regimen for menopausal hormonal therapy (MHT). However, more recent patient-centered studies revealed an increase in the incidence of breast cancer in women receiving menopausal hormone therapy with estrogen plus progestin rather th...

Descripción completa

Detalles Bibliográficos
Autores principales: Nair, Hareesh B., Santhamma, Bindu, Krishnegowda, Naveen K., Dileep, Kalarikkal V., Nickisch, Klaus J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4806908/
https://www.ncbi.nlm.nih.gov/pubmed/27011208
http://dx.doi.org/10.1371/journal.pone.0151182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4806908/
https://www.ncbi.nlm.nih.gov/pubmed/27011208
http://dx.doi.org/10.1371/journal.pone.0151182

Ejemplares similares